Feature | February 01, 2012| Dave Fornell

Cardiac Technology Trend Predictions for 2012

Based on my observations and those of the doctors on the Diagnostic & Interventional Cardiology Editorial Advisory Board, we created the following list of predictions of what will be hot trends to watch in 2012.


•  FFR-CT: A potential “game-changer” technology that was recently introduced is fractional flow reserve computed tomography (FFR-CT), which  computationally models coronary blood flow, pressure and physiology from static typically acquired by CT scans.  The information may be able to determine if a specific stenosis needs to be stented without the need for invasive, catheter FFR measurements in the cath lab.


•  Transcatheter Heart Valves: With the U.S. Food and Drug Administration (FDA) clearance of the Edwards Sapien valve (see story on Page 34), transcatheter aortic valve implantation (TAVI) is taking center stage at several conferences. Also in FDA trials are Medtronic’s CoreValve aortic valve and Abbott’s MitraClip device for mitral valve repair.


• Percutaneous Renal Nerve Ablation: Medtronic purchased Ardian, which developed the Symplicity renal nerve ablation catheter currently in FDA trial. Data so far has shown the therapy may greatly reduce drug-resistant hypertension.


• Left Atrial Appendage (LAA) Occluders:  These transcatheter occluders are designed to prevent atrial fibrillation-induced emboli and replace the current standard of warfarin therapy. In 2011 the CoHerex WaveCrest entered first-in-man trials and Boston Scientific purchased Atritech’s Watchman LAA occluder.


• Drug-Eluting Balloons: Several DEBs are already available in Europe and several vendors are seeking FDA clearance. Lutonix (purchased by C.R. Bard in December) has an ongoing FDA trial. Medrad, Cook and Medtronic/Invatec are working with the FDA to begin U.S. trials.


• Hybrid Operating Rooms: While hybrid ORs are not a new concept, the approval of the first transcatheter aortic valve and increasingly more complex minimally invasive surgeries and interventional procedures are driving their adoption. Vendors are increasingly emphasizing the hybrid OR applications of their products due to rising interest.


• Robotics in the Cath Lab: The Corindus CorPath 200 cath lab robotic system entered its FDA pivotal clinical trial with possible final review in 2012. Boston Scientific and Philips both partnered with robotic system vendors for closer integration. Hansen Medical is also developing a peripheral artery disease interventional robotic system it hopes will be reviewed in 2012 by the FDA. See the story on Page 8.


I am always interested in hearing readers’ thoughts on technologies or trial data from the past year, or in their predictions for what technologies to watch in the coming year.

Related Content

Nihon Kohden Launches Augmented Reality Electrophysiology Training App at HIMSS18
Technology | Advanced Visualization | March 06, 2018
Nihon Kohden announced the launch of the Nihon Kohden Dimensions Augmented Reality (AR) App to complement the Clinical...
NIH Issues $2.2 Million Grant for Augmented Reality Cardiac Hologram Research
News | Advanced Visualization | February 15, 2018
February 15, 2018 — The National Institutes of Health (NIH) awarded a $2.2 million research grant to healthcare techn
EchoPixel Showcases Next-Generation Surgical Planning With True 3-D Interactive Mixed Reality Software
News | Advanced Visualization | January 08, 2018
EchoPixel showcased the latest version of True 3D, its interactive, mixed reality software solution at the 103rd Annual...
Videos | Advanced Visualization | December 07, 2017
Dianna Bardo M.D., director of body MR and co-director of the 3-D Innovation Lab at Phoenix Children's Hospital, disc
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
December 4, 2017 — Vital Images unveiled the newest version of Vitrea...
Arterys Completes Series B to Accelerate Product Commercialization
News | Advanced Visualization | November 15, 2017
Arterys Inc. announced the close of its $30M Series B financing round. The investment was led by Temasek, with...
TeraRecon Introduces 175-Plus New Features in iNtuition 4.4.13
Technology | Advanced Visualization | November 06, 2017
November 6, 2017 — TeraRecton announced the launch of version 4.4.13 of its iNtuition...
TeraRecon Enhances Speed, Clinical Capabilities With Latest iNtuition Release
Technology | Advanced Visualization | October 25, 2017
October 25, 2017 — TeraRecon announced the release of version 4.4.13 of their iNtuition software, bringing over 175 n
Analytics 4 Life Raises $25 Million for AI-Backed Cardiac Imaging Technology
News | Advanced Visualization | October 20, 2017
October 20, 2017 — Digital health company Analytics 4 Life announced it has completed a $25 million Series B financin
Echopixel, True 3D Viewer, interactive virtual reality, pediatric surgery, increased clinical adoption
News | Advanced Visualization | March 21, 2017
March 21, 2017 — EchoPixel recently announced progress in the clinical adoption of its True 3D...
Overlay Init